Acute procedural efficacy and safety of a novel cryoballoon for the treatment of paroxysmal atrial fibrillation: Results from the POLAR ICE study.
Claire A MartinRoland R R TilzAnte AnicPascal DefayeArmin LuikCarlo de AsmundisLaure Champ-RigotSaverio IacopinoPhilipp SommerElizabeth M AlbrechtJonathan D RaybuckElizabeth RichardsNele CielenSing-Chien Yapnull nullPublished in: Journal of cardiovascular electrophysiology (2023)
This real-world usage data on a novel cryoballoon suggests this device is effective, safe, and relatively fast in centers with cryoballoon experience. These data are comparable to prior POLARx reports and in keeping with reported data on other cryoballoons. Future studies should examine the long-term outcomes and the relationship between biophysical parameters and outcomes for this novel cryoballoon.
Keyphrases
- atrial fibrillation
- catheter ablation
- left atrial appendage
- left atrial
- oral anticoagulants
- electronic health record
- radiofrequency ablation
- direct oral anticoagulants
- big data
- heart failure
- liver failure
- percutaneous coronary intervention
- type diabetes
- data analysis
- skeletal muscle
- metabolic syndrome
- current status
- acute coronary syndrome
- adverse drug
- combination therapy
- artificial intelligence
- insulin resistance